Clinical Trial Update: Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated adding dapagliflozin to insulin therapy in adults with type 2 diabetes inadequately controlled on insulin, assessing efficacy and safe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2013-08-23